Opto Circuits FDA nod for patient monitoring system

Opto Circuits (India) Ltd, a healthcare equipment manufacturer, said its subsidiary received a clearance from the US Food & Drug Administration (FDA) for its new modular patient monitoring system - eVision 9100.

The certification enables its unit Criticare Systems Inc to sell eVision 9100 in most parts of the world, particularly in the US, which is one of the largest markets for patient monitors. According to Global Markets Direct, the revenue for multi-parameter patient monitors is estimated to be around $2,249 million, it said in a regulatory filing.

On Monday, Opto Circuits shares ended 1% up at Rs282 on Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 18,560 points.

User

Anik Industries FY net profit up to Rs11.1 crore

Milk and milk products producer Anik Industries Ltd registered net profit of Rs11.1 crore for the year ended March 2010, a rise of 2.8%, as compared to Rs10.8 crore during the previous year ended March 2009.

Its total revenues rose 19.9% to Rs1,223.3 crore in the year ended March 2010 as against Rs1,021 crore during the previous year ended March 2009. Anik Industries recommended a dividend of 6% per equity share.

On Monday, Anik Industries shares declined 0.2% to Rs62 on Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 18,560 points.

User

Koutons Retail Q1 net profit dips 50% to Rs5.5 crore

Garments manufacturer and exporter Koutons Retail India Ltd said its net profit for the first quarter stood at Rs5.5 crore, a fall of 50%, as compared to Rs11 crore in the same quarter last year.

During the June 2010 quarter, its total revenues decreased to Rs161.5 crore, a decline of 20%, from Rs201.8 crore. Also, the company's net sales decreased 20.2% to Rs160.6 crore from Rs201.3 crore, Koutons Retail said in a regulatory filing.

On Monday, Koutons Retail shares ended 0.5% up at Rs317 on Bombay Stock Exchange, while the benchmark Sensex gained 1.9% to 18,560 points.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)